Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Neonatal jaundice in association with autism spectrum disorder and developmental disorder

Abstract

Objective

To examine the association between neonatal jaundice and autism spectrum disorder (ASD) and non-ASD developmental disorder (DD).

Study design

We analyzed data from the Study to Explore Early Development, a US multisite, case-control study conducted from 2007 to 2011. Developmental assessment classified children aged 2–5 years into: ASD (n = 636), DD (n = 777), or controls (POP; n = 926). Neonatal jaundice (n = 1054) was identified from medical records and maternal interviews. We examined associations between neonatal jaundice and ASD and DD using regression models to obtain adjusted odds ratios (aOR).

Results

Our results showed interaction between gestational age and neonatal jaundice. Neonatal jaundice was associated with ASD at 35–37 weeks (aOR = 1.83, 95%CI 1.05, 3.19), but not ≥38 weeks gestation (aOR = 0.97, 95%CI 0.76, 1.24). Similar results were observed with DD.

Conclusions

Further exploration of timing and severity of neonatal jaundice and ASD/DD is warranted.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1

References

  1. 1.

    American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.

    Book  Google Scholar 

  2. 2.

    Christensen DL, Braun KVN, Baio J, Bilder D, Charles J, Constantino JN, et al. Prevalence and characteristics of autism spectrum disorder among children aged 8 years–autism and developmental disabilities monitoring network, 11 sites, United States, 2012. Morb Mortal Wkly Rep Surveill Summ 2018;65: 1–23.

  3. 3.

    Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T, et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry. 2011;68:1095–102.

    Article  Google Scholar 

  4. 4.

    Lyall K, Schmidt RJ, Hertz-Picciotto I. Maternal lifestyle and environmental risk factors for autism spectrum disorders. Int J Epidemiol. 2014;43:443–64.

    Article  Google Scholar 

  5. 5.

    Maimburg RD, Vaeth M. Perinatal risk factors and infantile autism. Acta Psychiatr Scand. 2006;114:257–64.

    CAS  Article  Google Scholar 

  6. 6.

    Bilder D, Pinborough-Zimmerman J, Miller J, McMahon W. Prenatal, perinatal, and neonatal factors associated with autism spectrum disorders. Pediatrics. 2009;123:1293–1300.

    Article  Google Scholar 

  7. 7.

    Buchmayer S, Johansson S, Johansson A, Hultman CM, Sparen P, Cnattingius S. Can association between preterm birth and autism be explained by maternal or neonatal morbidity? Pediatrics. 2009;124:e817–25.

    Article  Google Scholar 

  8. 8.

    Dennery PA, Seidman DS, Stevenson DK. Neonatal hyperbilirubinemia. N Engl J Med. 2001;344:581–90.

    CAS  Article  Google Scholar 

  9. 9.

    Cohen SM. Jaundice in the full-term newborn. Pediatr Nurs. 2006;32:202–8.

    PubMed  Google Scholar 

  10. 10.

    Johnson LH, Bhutani VK, Brown AK. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr. 2002;140:396–403.

    Article  Google Scholar 

  11. 11.

    Shapiro SM. Bilirubin toxicity in the developing nervous system. Pediatr Neurol. 2003;29:410–21.

    Article  Google Scholar 

  12. 12.

    Brito MA, Palmela I, Cardoso FL, Sa-Pereira I, Brites D. Blood-brain barrier and bilirubin: clinical aspects and experimental data. Arch Med Res. 2014;45:660–76.

    CAS  Article  Google Scholar 

  13. 13.

    Bhutani VK, Johnson LH. Newborn jaundice and kernicterus–health and societal perspectives. Indian J Pediatr. 2003;70:407–16.

    Article  Google Scholar 

  14. 14.

    Johnson L, Bhutani VK. The clinical syndrome of bilirubin-induced neurologic dysfunction. Semin Perinatol. 2011;35:101–13. Jun

    Article  Google Scholar 

  15. 15.

    Maimburg RD, Vaeth M, Schendel DE, Bech BH, Olsen J, Thorsen P. Neonatal jaundice: a risk factor for infantile autism? Paediatr Perinat Epidemiol. 2008;22:562–8.

    Article  Google Scholar 

  16. 16.

    Maimburg RD, Bech BH, Vaeth M, Moller-Madsen B, Olsen J. Neonatal jaundice, autism, and other disorders of psychological development. Pediatrics. 2010;126:872–8.

    Article  Google Scholar 

  17. 17.

    Mamidala MP, Polinedi A, TVP P, Rajesh N, Vallamkonda OR, Udani V, et al. Prenatal, perinatal and neonatal risk factors of Autism Spectrum Disorder: a comprehensive epidemiological assessment from India. Res Dev Disabil. 2013;B:3004–13.

    Article  Google Scholar 

  18. 18.

    Duan G, Yao M, Ma Y, Zhang W. Perinatal and background risk factors for childhood autism in central China. Psychiatry Res. 2014;220:410–7.

    Article  Google Scholar 

  19. 19.

    Croen LA, Yoshida CK, Odouli R, Newman TB. Neonatal hyperbilirubinemia and risk of autism spectrum disorders. Pediatrics. 2005;115:e135–8.

    Article  Google Scholar 

  20. 20.

    Froehlich-Santino W, Londono Tobon A, Cleveland S, Torres A, Phillips J, Cohen B, et al. Prenatal and perinatal risk factors in a twin study of autism spectrum disorders. J Psychiatr Res. 2014;54:100–8.

    Article  Google Scholar 

  21. 21.

    Evans D. Neonatal jaundice. BMJ Clin Evid. 2007;06:0319.

    Google Scholar 

  22. 22.

    Atladottir HO, Schendel DE, Henriksen TB, Hjort L, Parner ET. Gestational age and autism spectrum disorder: trends in risk over time. Autism Res. 2016;9:224–31.

    CAS  Article  Google Scholar 

  23. 23.

    Schendel DE, Diguiseppi C, Croen LA, Fallin MD, Reed PL, Schieve LA, et al. The Study to Explore Early Development (SEED): a multisite epidemiologic study of autism by the Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE) network. J Autism Dev Disord. 2012;42:2121–40.

    Article  Google Scholar 

  24. 24.

    Rutter M, Bailey A, Lord C. SCQ: Social Communication Questionnaire. Los Angeles, CA: Western Psychological Services; 2003.

    Google Scholar 

  25. 25.

    Gotham K, Risi S, Pickles A, Lord C. The Autism Diagnostic Observation Schedule: revised algorithms for improved diagnostic validity. J Autism Dev Disord. 2007;37:613–27.

    Article  Google Scholar 

  26. 26.

    Lord C, Rutter M, Le Couteur A. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord. 1994;24:659–85.

    CAS  Article  Google Scholar 

  27. 27.

    Wiggins LD, Reynolds A, Rice CE, Moody EJ, Bernal P, Blaskey L, et al. Using standardized diagnostic instruments to classify children with autism in the study to explore early development. J Autism Dev Disord. 2015;45:1271–80.

    Article  Google Scholar 

  28. 28.

    Mullens EM. Mullen scales of early learning. Circle Pines, MN: American Guidance Service. Inc.; 1995.

    Google Scholar 

  29. 29.

    American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297–316.

    Article  Google Scholar 

  30. 30.

    Shrier I, Platt RW. Reducing bias through directed acyclic graphs. BMC Med Res Method. 2008;8:70.

    Article  Google Scholar 

  31. 31.

    Oh W, Tyson JE, Fanaroff AA, Vohr BR, Perritt R, Stoll BJ, et al. Association between peak serum bilirubin and neurodevelopmental outcomes in extremely low birth weight infants. Pediatrics. 2003;112:773–9.

    Article  Google Scholar 

  32. 32.

    Jangaard KA, Fell DB, Dodds L, Allen AC. Outcomes in a population of healthy term and near-term infants with serum bilirubin levels of >or = 325 micromol/L (>or = 19 mg/dL) who were born in Nova Scotia, Canada, between 1994 and 2000. Pediatrics. 2008;122:119–24.

    Article  Google Scholar 

  33. 33.

    Wu YW, Kuzniewicz MW, Croen L, Walsh EM, McCulloch CE, Newman TB. Risk of autism associated with hyperbilirubinemia and phototherapy. Pediatrics. 2016;138:e20161813.

    Article  Google Scholar 

Download references

Acknowledgements

The authors would like to acknowledge Chyrise Bradley for study coordination assistance. CC was supported by NICHD T32HD052468—Training Program in Reproductive, Perinatal and Pediatric Epidemiology. The Study to Explore Early Development is funded by the Centers for Disease Control and Prevention: Cooperative Agreement Number U10DD000180, Colorado Department of Public Health and Environment, and U10DD000750, University of Colorado Denver; Cooperative Agreement Number U10DD000181, Kaiser Foundation Research Institute (CA); Cooperative Agreement Number U10DD000182, University of Pennsylvania; Cooperative Agreement Number U10DD000183, Johns Hopkins University; Cooperative Agreement Number U10DD000184, University of North Carolina at Chapel Hill; and Cooperative Agreement Number U10DD000498, Michigan State University.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Christina Cordero.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Cordero, C., Schieve, L.A., Croen, L.A. et al. Neonatal jaundice in association with autism spectrum disorder and developmental disorder. J Perinatol 40, 219–225 (2020). https://doi.org/10.1038/s41372-019-0452-4

Download citation

Further reading

Search

Quick links